Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank79
3Y CAGR+125.0%
5Y CAGR-28.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+125.0%/yr
Annual compound
5Y CAGR
-28.3%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.05 | -17.3% |
| 2023 | 0.06 | +49.6% |
| 2022 | 0.04 | +821.0% |
| 2021 | 0.00 | -65.0% |
| 2020 | 0.01 | -95.2% |
| 2019 | 0.25 | +749.1% |
| 2018 | 0.03 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | -100.0% |
| 2015 | 0.01 | - |